Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals

Fig. 2

Boxplot comparing the number of mutations at diagnosis across different patient groups stratified by immunosuppression type. The groups include patients with autoimmune or inflammatory diseases, hematological oncology, HIV infection, intensive care admission, oncology, respiratory diseases, treatment with rituximab, and solid organ transplantation, as well as controls. The boxplots represent the median, interquartile range (IQR), and the range of observed values, with outliers shown as individual points. Notably, patients admitted to intensive care exhibit a higher number of mutations compared to most other groups, while controls have a lower average mutation count

Back to article page